chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe chills, temperature of 101, excessive urination (every 45 minutes -1 hour), constant, ever headache, scratchy throat, weakness, sporadic pain in lower right side; all afore-mentioned symptoms lasting for approximately 12 hours, except temperature of 99.7 carried over through the subsequent several hours.
This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (Didn't get their period until 3 months after their vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (Didn't get their period until 3 months after their vaccine). At the time of the report, MENSTRUATION DELAYED (Didn't get their period until 3 months after their vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. No treatment medications were provided. This case was linked to MOD-2022-471320 (Patient Link).
See previous answers above.  Swollen face since 3/24/2022,  fever, headaches.   Given her Motrin, Tylenol, Benadryl, zertech, Allegra.
This case was reported by a healthcare professional via a sales representative and described the occurrence of swelling injection site in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of KINRIX (unknown, unknown thigh). At an unspecified time after vaccination with KINRIX, the subject experienced swelling injection site, limb swelling, and vaccine administered at inappropriate site. For KINRIX, the preferred site of administration is the deltoid muscle of the upper arm. The healthcare professional reported that two children were vaccinated with KINRIX and both children developed limb swelling at the injection site (see case id A0891208A for details on the other child's case). The reporter was not aware if the limb swelling was on the same area as the injection. One child was injected in the arm and the other in the thigh. No other adverse events were reported. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were probably related to vaccination with KINRIX.
Pain at injection site; muscle aches; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 27Apr2022 at 10:00 as dose 4 (booster), single (Lot number: FL3197) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATORVASTATIN; LISINOPRIL. Vaccination history included: Covid-19 vaccine (Dose: 01, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 02, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 03, Unknown manufacturer), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 27Apr2022 at 22:00, outcome "recovering", described as "Pain at injection site"; HEADACHE (non-serious) with onset 27Apr2022 at 22:00, outcome "recovering"; MYALGIA (non-serious) with onset 27Apr2022 at 22:00, outcome "recovering", described as "muscle aches". Therapeutic measures were not taken as a result of vaccination site pain, myalgia, headache.  Additional information: No other vaccine in four weeks. Other medications in two weeks: Atorvastatin and Lisinopril. No covid prior vaccination. No covid tested post vaccination.
expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter.
Localized reaction of pink, warm, swollen arm with tenderness; three patients who got 6 doses injected at one time and overdose; This is a spontaneous report from a contactable physician. This physician reported for a 23-year-old female patient. A 23-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EWO187; Expiration Date: 31Aug2021), dose 1 via an unspecified route of administration on 17Aug2021 as a single dose for covid-19 immunization. Medical history included covid-19 from 20May2021 to 20May2021 Hospitalized due to Covid and experienced psychosis during Covid infection. The psychosis was controlled with medicine and had resolved by the time patient received vaccine. Concomitant medication(s) included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]); aripiprazole (ABILIFY); calcium carbonate (TUMS FRESHERS ANTACID); famotidine; clindamycin hydrochloride; ethinylestradiol, levonorgestrel (ASHLYNA); metformin; sertraline hcl; ipratropium bromide, salbutamol sulfate (DUONEB); amitriptyline. On 17Aug2021, It was reported that they have three patients (16 years old male, 23 years old female, and 37 year old female) who got 6 doses injected at one time and overdose. She wants to know if we have information on this situation and what advice can she give to her patients. The patient experienced localized reaction of pink, warm, swollen arm with tenderness on an unspecified date. Outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101065126 same reporter/drug/event with different patient
Site: Swelling at Injection Site-Mild, Systemic: reported \"heaviness\" in arm and shoulder, swelling of arm and neck area-Mild, Additional Details: no numbness, tingling, or decreased circulation. 25mg diphenhydramine given\r\nsymptoms occured 2+ hours after immunization administered, patient observed for 1 hour post reporting, no increase or worsening of condition
sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left injection site arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (sore left injection site arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-403139 (Patient Link).
can't sleep; keep coughing; joints in fingers hurt; headache; This case was reported by a consumer via interactive digital media and described the occurrence of insomnia in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   On 28th September 2022, the patient received Flu vaccine and COVID-19 VACCINE. On an unknown date, unknown after receiving Flu vaccine, the patient experienced insomnia, cough, joint pain and headache. On an unknown date, the outcome of the insomnia, cough, joint pain and headache were not recovered/not resolved.   It was unknown if the reporter considered the insomnia, cough, joint pain and headache to be related to Flu vaccine.     Additional Information: GSK Receipt Date: 29-SEP-2022 Reporter's comment: The patient self-reported this case via media. The patient got the flu and COVID booster yesterday (day before reporting) and he/she cannot sleep because he/she was keep coughing and his/her joints in his/her fingers hurt and he/she had a headache. Additional Supportive Information: The follow-up would not possible, as no contact, details were available.
High fever about 6 hours after administration. 24 hours after administration loss of taste and smell. 48 hours after administration i tested positive for COVID-19.
pt recvd vax; 4 hrs later had a limp episode;mom ran outside thinking cold air would help;8 hrs later pt became pale limp & had tonic clonic sz lasting 1 min; called 911;to er;for several hrs was very cranky & "out of it"; max t 103;
Patient died of an aortic dissection 13 days after receiving vaccine.  It is not clear if there was any correlation.
Pt received vaccine on 11-4-08, called on 11-6-08 and reported injection site swollen and the area of redness had gotten larger to approximately 3 inches.
Client received hep B #1 on 1/19/99, #2 on 4/7/99, #3 on 8/10/99. Parents stated that child started acting strange 24 hrs after first Hp B vaccine. She started staring into space, complained of being tired and grades dropped over period of time. She had the first seizure on 8/6/99 at a friend's house and fell off the chair. After the second Hp B vaccine, she started drooling and wet the bed twice over a period of time. After the third vaccination, seizures became progressively worse. Child was under the care of the neurologist and medical services. On 10/13/01 child died in her sleep as a result of a "brain seizure."
Information has been received from a registered nurse concerning a 5 year old white female child with a sulfamethoxazole (+) trimethoprim (Bactrim) allergy who on 16 AUG 1999 was vaccinated "H" in the left arm with a first dose of varicella virus vaccine live (lot #631067/0447J). The child was reported to have been well at the time of vaccination. On 29 JUN 2001 the child erupted with 25-50 fluid filled lesions and complained of mild itching. It was noted that the child a afebrile. The child was treated with benzocaine (+) triclosan (+) camphor (Solarcaine), calamine (+) camphor (+) pramoxine hydrochloride (AVEENO), and calamine (+) camphor (+) diphenhydramine hydrochloride (CALADRYL). It was noted that the child had mild upper respiratory symptoms for a few days prior to the experience. On 05 JUL 2001 the patient recovered. It was reported that the child had a sibling that died from a heart defect. No further information is available.
12 hours after the vaccination, I had a low grade fever ranging from 99.8 to 101.4 and was so cold my body would not stop shaking and my teeth chattering.  Then, in the morning, my fever had broken, but I felt very nauseous and dizzy every time I stood up for the next 5 hours.
Area around injection site (Right Deltoid) started to swell, turn red and was warm to the touch.  Swelling subsided the next day but was still red and warm.  Area covered roughly 6 inches.
Had and continue with left side of facefeeling fuzzy; Lightheaded and dizziness more than usual; extreme joint pain in joints that usually do not hurt; Diarrhea; Exhausted and so tired; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included hip replacement (need hip replacement), thyroid disorder, hand osteoarthritis, osteoarthritis knees, hips osteoarthritis, heart murmur, penicillin allergy, iodine allergy and drug allergy (theramosol allergy). Concomitant medications included CELEBREX, omeprazole (MANUFACTURER UNKNOWN), ropinirole (MANUFACTURER UNKNOWN) and SYNTHROID. The patient previously took Benadryl and experienced allergy (allergic to benadryl). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 06:30, the patient experienced extreme joint pain in joints that usually do not hurt, lightheaded and dizziness more than usual, diarrhea, exhausted and so tired, also had and continue with left side of face feeling fuzzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded and dizziness more than usual, extreme joint pain in joints that usually do not hurt, diarrhea and exhausted and so tired were recovered/resolved with sequelae on 21Mar2021. The clinical outcome of the event left side of face feeling fuzzy was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Shingles 5/11, Narcolepsy, 3/13/2021 both ran it's course and is no longer an issue as of 07/01/2021.
spreading; rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) and VACCINATION SITE RASH (spreading) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was reported.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (rash). On 14-Mar-2021, the patient experienced VACCINATION SITE RASH (spreading). The patient was treated with PREDNISONE at an unspecified dose and frequency; FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (rash) and VACCINATION SITE RASH (spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided.
Red rash on arm where injection was given.  It presented itself on Feb 7, 2021.   10 days post inoculation.
Pregnancy: EDD is 3/22/21, was 38w5d when received dose. No complications so far Adverse events: started getting chills that evening around 930pm, had fever and chills through the night. Took 2 over the counter acetaminophen pills around 6am. Next day-- chills started coming back around 12p, took another dose of acetaminophen, spent the day mostly on the couch, sleeping. Another dose acetaminophen around 10pm. No chills or fever that night, woke up feeling much better on Monday 3/15
Received chicken pox vaccine: Developed full-blown case of chicken pox from vaccine. Started with 2 days low-grade fever. Developed 300+ pox. Case is still ongoing with 3rd wave of 100 additional pox on 1/18/2013.
Pt reports chest tightness, tongue numbness, normal EKG.  Pt recovered
The patient was seen on 7/28/21 in the ED for SOB and chest pain and tested positive for covid.  The patient was discharged home from the ED and was not admitted. On 12/07/2020 the patient was admitted as an inpatient for pneumonia due to Covid 19 virus so this is the second positive covid for this patient.  Also, the patient was an observation patient on med/surg between 6/24-6/26/2021 for COPD exacerbation.  The patient was fully vaccinated at the time of his second infection.
After 3 weeks, I start feeling joint pain on my right knee. The next day I wake with pain of my left foot and the circle of pain started. The next day my other knee didn't work, my middle finger on the left hand swelled and I could bend it.  The right pinky start hurting and my back also hurts.
Shortly after receiving my COVID-19 booster shot, my right deltoid began hurting and aching. My deltoid hurt so for 6-8 weeks after the shot. I would rate is at 6/10 with movements such as bench press and describe it as an intense sharp pain over the injection site. I had to greatly modify my workout routine as I could only bench half of the weight I had been lifting because of pain in my shoulder. The pain in my right deltoid has slowly dissipated but is still present at a 1-2/10 when I bench while lifting.  I developed swelling and discomfort in the medial compartment of my right forearm around holiday in 2021. This swelling and discomfort last for 3-4 weeks but as it has gone away pain over the dorsal aspect of my right wrist has appeared. Currently, I am only able to curl half the weight I used while working out because any curling motion with my hand supinated cause a great deal of pain over the dorsal side of my right wrist starting 2-3 cm proximal to my ulnar and going proximally 8-10 cm. I have had no acute injuries to my RUE during this time.,
deep cough - whooping cough; Severe diarrhea; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had not resolved. Not Provided          No relevant concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Follow-up received on 05APR2021 included no new information This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (deep cough - whooping cough), DIARRHOEA (Severe diarrhea), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had not resolved. Not Provided          No relevant concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Follow-up received on 05APR2021 included no new information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Case number PHEH2013US003051 is an initial spontaneous report received from a health care professional on 01 Feb 2013. This report refers to an adult female patient. It was reported that she might have received only 0.5 ml Men CYW-135 liquid component of MENVEO (batch number: M11081, expiry date: Apr 2014) intramuscularly and did not receive MenA lyophilized conjugate on 04 Dec 2012. No adverse reaction was reported. No further information was available.
tingling of hands & feet 31OCT progressed to reflexia ascending paresthesias, weakness;seen by neurologist readmitted to hosp 3NOV;5 days of IV IG;starting to improve still hosp as of 14NOV;dx GBS:numbness in fingers & toes;pt had back pain
very few patients experienced fever following Shingrix administration.; This case was reported by a other health professional via call center representative and described the occurrence of fever in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patients received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patients experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for this report. very few patients experienced fever following Shingrix administration. lot number and expiration date not available.  No additional information was available. The reporter consented to follow up.  This case is 1 out of 4 cases reported by the same reporter.
Soreness in upper arm for 48 hours with a rash and hives.  Had a bad headache the night and morning after the vaccine was given.  Rash on arm is persisting.
Vaccine adminitered on 5/10/07, R arm became red,warm to touch and slightly swollen.  Administered Benadryl 50mg q6h prn and Prednisone 40mg x3 days with total resolution of localized reaction.
I21.4 ACUTE NON ST ELEVATION MI 6/2/2021 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 6/2/2021 ATHEROSCLEROSIS OF AORTA J96.00 ACUTE RESPIRATORY FAILURE 6/24/2021 ATHEROSCLEROSIS OF AORTA I21.4 ACUTE NON ST ELEVATION MI 6/2/2021 TRANSITIONAL CELL CARCINOMA, LEFT URETER I95.9 HYPOTENSION 6/2/2021 TRANSITIONAL CELL CARCINOMA, LEFT URETER J96.00 ACUTE RESPIRATORY FAILURE 6/24/2021 TRANSITIONAL CELL CARCINOMA, LEFT URETER I21.4 ACUTE NON ST ELEVATION MI 6/2/2021 DM 2 W HYPERLIPIDEMIA    EFFUSION OF RIGHT WRIST I95.9 HYPOTENSION 6/2/2021 DM 2 W HYPERLIPIDEMIA    EFFUSION OF RIGHT WRIST J96.00 ACUTE RESPIRATORY FAILURE 6/24/2021 DM 2 W HYPERLIPIDEMIA    EFFUSION OF RIGHT WRIST
Baby looks like she has involuntary movements with her head and she?s is nodding her head at random wall moments in a jerking motion burn hrs in betweenness.